Uppsala Monitoring Centre (UMC) has been at the forefront of medicines safety for over 40 years. As an independent, non-profit foundation, UMC collaborates with the World Health Organization (WHO) and stakeholders worldwide to advance the science of pharmacovigilance and support global patient safety initiatives. UMC conducts pharmacovigilance research, develops products, and fosters collaborations with medicines safety stakeholders around the world.

With a vision to advance medicines safety together with key stakeholders worldwide, UMC works towards influencing the lives and safety of patients for the better. Their dedicated team of staff members, from diverse academic backgrounds, work in research, product and system development, international collaboration and education, communications, and core operational services. UMC offers a range of products and services used by health authorities and the pharmaceutical industry.

They provide scientific advancement and operational support to the WHO Programme for International Drug Monitoring. Popular products include WHODrug, VigiBase Services, and PV Solutions. For over four decades, UMC has been a trusted organization in the field of medicines safety, making a significant impact on global healthcare